RESTASIS MULTIDOSE
Google image searchProduct monograph
Active ingredient
cyclosporine, 0.05 %/W/V
DIN: 02476835
Dosage form(s): EMULSION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 19-JUL-2023
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01X — OTHER OPHTHALMOLOGICALS (ATC, ATC/DDD)
- S01XA — Other ophthalmologicals (ATC, ATC/DDD)
- S01XA18 — CICLOSPORIN (ATC/DDD)
Reference brand drug: Neoral, Sandimmune
Pharmaceutical standard: MFR
